Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Goldline Pharmaceutical Ltd

BSE: 544759 · Pharmaceuticals & Biotechnology · 9 announcements

Share price
₹33.00
Market cap
₹31.68 Cr
Revenue (annual)
₹31.20 Cr
Net profit (annual)
₹4.12 Cr
P/E (TTM)
7.7×Sector 47.4×
Promoter holding
57.29%
FII holding
5.16%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:18 IST BSE
Other Announcement

Goldline Pharmaceutical Other Announcement

Goldline Pharmaceutical Ltd announced the closure of its Register of Members and Share Transfer Books from August 23 to August 29, 2026, for its AGM.